| Literature DB >> 21395508 |
Wayne A Schroder1, Lee Major, Andreas Suhrbier.
Abstract
SerpinB2 or plasminogen activator inhibitor type 2 (PAI-2) is widely described as an inhibitor of extracellular urokinase plasminogen activator. However, the evidence that this represents the physiological role of SerpinB2 is not overly compelling. SerpinB2 is substantially up-regulated under multiple inflammatory conditions, and dysregulated expression and polymorphisms are associated with several human inflammatory diseases. A bewildering array of diverse functions and activities have been attributed to SerpinB2, but despite ≈900 publications in the field, no coherent view of what SerpinB2 does in vivo has emerged. Although SerpinB2 is abundantly expressed by activated macrophages and a range of other haematopoietic and non-haematopoietic cells, SerpinB2(-/-) mice have surprisingly few phenotypes. However, SerpinB2(-/-) mice were recently shown to generate increased Th1 responses, suggesting that at least one function of SerpinB2 is sculpting of the adaptive immune response.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21395508 DOI: 10.1615/critrevimmunol.v31.i1.20
Source DB: PubMed Journal: Crit Rev Immunol ISSN: 1040-8401 Impact factor: 2.214